Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Imaging for the Evaluation of Transthyretin Cardiac Amyloidosis Prevalence of Patients Over 65 Hospitalized in Cardiology Wards (the IMPACT Study)

NCT05064839 is registered in ClinicalTrials.gov with Poitiers University Hospital as lead sponsor.

NCT NCT05064839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05064839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Imaging for the Evaluation of Transthyretin Cardiac Amyloidosis Prevalence of Patients Over 65 Hospitalized in Cardiology Wards (the IMPACT Study)
Lead sponsor
Poitiers University Hospital
Phase
Phase 3
Overall status
Completed
Start date
October 6, 2021
Completion date
August 18, 2023
Enrollment
553 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

transthyretin cardiac amyloidosis